{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:18:12Z","timestamp":1789417092813,"version":"build-2803163510"},"reference-count":109,"publisher":"Xia & He Publishing","issue":"000","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,27]]},"DOI":"10.14218\/jcth.2021.00051","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T22:43:49Z","timestamp":1622069029000},"page":"000-000","source":"Crossref","is-referenced-by-count":8,"title":["B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection"],"prefix":"10.14218","volume":"000","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxia","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahma","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"key20210526224342_JCTH-D-21-00051-b1","doi-asserted-by":"crossref","first-page":"18036","DOI":"10.1038\/nrdp.2018.36","article-title":"Hepatitis B virus infection","volume":"4","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3851\/IMP1497","article-title":"Hepatitis B surface antigen seroclearance during chronic HBV infection","volume":"15","author":"Chu","year":"2010","journal-title":"Antivir Ther"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J Hepatol"},{"issue":"4","key":"key20210526224342_JCTH-D-21-00051-b4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cld.2016.06.002","article-title":"Interferon treatment for hepatitis B","volume":"20","author":"Konerman","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"1","key":"key20210526224342_JCTH-D-21-00051-b5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12889-017-4549-4","article-title":"Associations between national viral hepatitis policies\/programmes and country-level socioeconomic factors: a sub-analysis of data from the 2013 WHO viral hepatitis policy report","volume":"18","author":"Lazarus","year":"2017","journal-title":"BMC Public Health"},{"issue":"9663","key":"key20210526224342_JCTH-D-21-00051-b6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"key20210526224342_JCTH-D-21-00051-b7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2019.11.003","article-title":"Guidance for design and endpoints of clinical trials in chronic hepatitis B - report from the 2019 EASL-AASLD HBV treatment endpoints conference (double dagger)","volume":"72","author":"Cornberg","year":"2020","journal-title":"J Hepatol"},{"issue":"4","key":"key20210526224342_JCTH-D-21-00051-b8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jhep.2017.05.008","article-title":"Hepatitis B cure: From discovery to regulatory approval","volume":"67","author":"Lok","year":"2017","journal-title":"J Hepatol"},{"key":"key20210526224342_JCTH-D-21-00051-b9","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14801","article-title":"Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimens","author":"Pan","year":"2021","journal-title":"Liver Int"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11938-019-00236-3","article-title":"Updates on chronic HBV: current challenges and future goals","volume":"17","author":"Lee","year":"2019","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3350\/cmh.2018.0106","article-title":"Unmet need in chronic hepatitis B management","volume":"25","author":"Liang","year":"2019","journal-title":"Clin Mol Hepatol"},{"issue":"7","key":"key20210526224342_JCTH-D-21-00051-b12","doi-asserted-by":"crossref","first-page":"e21698","DOI":"10.1371\/journal.pone.0021698","article-title":"High frequency of CD4+ CXCR5+ TFH cells in patients with immune-active chronic hepatitis B","volume":"6","author":"Feng","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"key20210526224342_JCTH-D-21-00051-b13","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1651-2227.2003.tb02477.x","article-title":"Decreased immune response to hepatitis B eight years after routine vaccination in Israel","volume":"92","author":"Gold","year":"2003","journal-title":"Acta Paediatr"},{"issue":"4","key":"key20210526224342_JCTH-D-21-00051-b14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0377-1237(08)80013-5","article-title":"Antibody to hepatitis B surface antigen in vaccinated health care workers","volume":"64","author":"Chaudhari","year":"2008","journal-title":"Med J Armed Forces India"},{"issue":"5","key":"key20210526224342_JCTH-D-21-00051-b15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/BF00145379","article-title":"Long-term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults","volume":"8","author":"Dentico","year":"1992","journal-title":"Eur J Epidemiol"},{"issue":"9959","key":"key20210526224342_JCTH-D-21-00051-b16","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Trepo","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"key20210526224342_JCTH-D-21-00051-b17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2006.10.007","article-title":"Occult hepatitis B virus infection","volume":"46","author":"Raimondo","year":"2007","journal-title":"J Hepatol"},{"issue":"23","key":"key20210526224342_JCTH-D-21-00051-b18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7748\/ns.3.23.30.s47","article-title":"Cancer support groups: a friend at hand","volume":"3","author":"Alderson","year":"1989","journal-title":"Nurs Stand"},{"issue":"3","key":"key20210526224342_JCTH-D-21-00051-b19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/cmi.2015.25","article-title":"Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients","volume":"12","author":"Xu","year":"2015","journal-title":"Cell Mol Immunol"},{"issue":"16","key":"key20210526224342_JCTH-D-21-00051-b20","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.1128\/JVI.77.16.8882-8892.2003","article-title":"Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions","volume":"77","author":"Schilling","year":"2003","journal-title":"J Virol"},{"issue":"6","key":"key20210526224342_JCTH-D-21-00051-b21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3851\/IMP3259","article-title":"The role of anti-HBs in hepatitis B reactivation during direct-acting antiviral therapy for chronic hepatitis C","volume":"23","author":"Spaan","year":"2018","journal-title":"Antivir Ther"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/viro.1993.1391","article-title":"IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells","volume":"195","author":"Outlaw","year":"1993","journal-title":"Virology"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b23","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1073\/pnas.79.2.650","article-title":"Selecting binding and complement-mediated lysis of human hepatoma cells (PLC\/PRF\/5) in culture by monoclonal antibodies to hepatitis B surface antigen","volume":"79","author":"Shouval","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"key20210526224342_JCTH-D-21-00051-b24","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/MEG.0000000000001130","article-title":"Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy","volume":"30","author":"Su","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"key20210526224342_JCTH-D-21-00051-b25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab","volume":"27","author":"Yeo","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"key20210526224342_JCTH-D-21-00051-b26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12072-019-09966-z","article-title":"Prediction and clinical implications of HBV reactivation in lymphoma patients with resolved HBV infection: focus on anti-HBs and anti-HBc antibody titers","volume":"13","author":"Nishida","year":"2019","journal-title":"Hepatol Int"},{"issue":"1","key":"key20210526224342_JCTH-D-21-00051-b27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/TP.0b013e31818bfc85","article-title":"Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients","volume":"87","author":"Schumann","year":"2009","journal-title":"Transplantation"},{"key":"key20210526224342_JCTH-D-21-00051-b28","doi-asserted-by":"crossref","first-page":"e26738","DOI":"10.7554\/eLife.26738","article-title":"A potent human neutralizing antibody Fc-dependently reduces established HBV infections","volume":"6","author":"Li","year":"2017","journal-title":"Elife"},{"issue":"10","key":"key20210526224342_JCTH-D-21-00051-b29","doi-asserted-by":"crossref","first-page":"e20200840","DOI":"10.1084\/jem.20200840","article-title":"Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers","volume":"217","author":"Hehle","year":"2020","journal-title":"J Exp Med"},{"issue":"4","key":"key20210526224342_JCTH-D-21-00051-b30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/gutjnl-2014-308964","article-title":"Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen","volume":"65","author":"Zhang","year":"2016","journal-title":"Gut"},{"issue":"9","key":"key20210526224342_JCTH-D-21-00051-b31","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1080\/21645515.2020.1763686","article-title":"Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody","volume":"16","author":"Zankharia","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"Pt 1","key":"key20210526224342_JCTH-D-21-00051-b32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1099\/vir.0.18678-0","article-title":"Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent","volume":"84","author":"Lazdina","year":"2003","journal-title":"J Gen Virol"},{"issue":"3","key":"key20210526224342_JCTH-D-21-00051-b33","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.4049\/jimmunol.135.3.1661","article-title":"Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors","volume":"135","author":"Abbas","year":"1985","journal-title":"J Immunol"},{"issue":"6011","key":"key20210526224342_JCTH-D-21-00051-b34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/314537a0","article-title":"Antigen-specific interaction between T and B cells","volume":"314","author":"Lanzavecchia","year":"1985","journal-title":"Nature"},{"issue":"3","key":"key20210526224342_JCTH-D-21-00051-b35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4049\/jimmunol.126.3.1075","article-title":"Studies on the capacity of B cells to serve as antigen-presenting cells","volume":"126","author":"Chesnut","year":"1981","journal-title":"J Immunol"},{"issue":"5","key":"key20210526224342_JCTH-D-21-00051-b36","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1084\/jem.162.5.1695","article-title":"Role of membrane immunoglobulin (Ig) crosslinking in membrane Ig-mediated, major histocompatibility-restricted T cell-B cell cooperation","volume":"162","author":"Tony","year":"1985","journal-title":"J Exp Med"},{"issue":"1","key":"key20210526224342_JCTH-D-21-00051-b37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1084\/jem.168.1.293","article-title":"Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen","volume":"168","author":"Jin","year":"1988","journal-title":"J Exp Med"},{"issue":"3","key":"key20210526224342_JCTH-D-21-00051-b38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1515\/BC.1999.039","article-title":"Enhancing the immunogenicity of exogenous hepatitis B surface antigen-based vaccines for MHC-I-restricted T cells","volume":"380","author":"Schirmbeck","year":"1999","journal-title":"Biol Chem"},{"issue":"1","key":"key20210526224342_JCTH-D-21-00051-b39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41426-018-0034-0","article-title":"Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans","volume":"7","author":"Tian","year":"2018","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"key20210526224342_JCTH-D-21-00051-b40","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4049\/jimmunol.167.3.1313","article-title":"4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy","volume":"167","author":"Cannons","year":"2001","journal-title":"J Immunol"},{"issue":"5","key":"key20210526224342_JCTH-D-21-00051-b41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jmv.25377","article-title":"HBcAg-induced upregulated 4-1BB ligand on B cells contributes to B-cell hyperactivation during chronic hepatitis B infection","volume":"91","author":"Liu","year":"2019","journal-title":"J Med Virol"},{"issue":"1 Suppl","key":"key20210526224342_JCTH-D-21-00051-b42","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.jhep.2016.01.026","article-title":"Adaptive immunity in HBV infection","volume":"64","author":"Bertoletti","year":"2016","journal-title":"J Hepatol"},{"issue":"10","key":"key20210526224342_JCTH-D-21-00051-b43","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1172\/JCI121957","article-title":"PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection","volume":"128","author":"Salimzadeh","year":"2018","journal-title":"J Clin Invest"},{"key":"key20210526224342_JCTH-D-21-00051-b44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12967-014-0251-9","article-title":"Increased numbers of CD5+CD19+CD1dhighIL-10+ Bregs, CD4+Foxp3+ Tregs, CD4+CXCR5+Foxp3+ follicular regulatory T (TFR) cells in CHB or CHC patients","volume":"12","author":"Wang","year":"2014","journal-title":"J Transl Med"},{"issue":"5","key":"key20210526224342_JCTH-D-21-00051-b45","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1182\/blood-2003-05-1403","article-title":"Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy","volume":"102","author":"Westhoff","year":"2003","journal-title":"Blood"},{"issue":"1 Suppl","key":"key20210526224342_JCTH-D-21-00051-b46","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2014.06.035","article-title":"Innate and adaptive immune responses in HCV infections","volume":"61","author":"Heim","year":"2014","journal-title":"J Hepatol"},{"issue":"1","key":"key20210526224342_JCTH-D-21-00051-b47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2249.1996.d01-732.x","article-title":"Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection","volume":"105","author":"Bocher","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"key20210526224342_JCTH-D-21-00051-b48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaci.2008.04.034","article-title":"Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease","volume":"122","author":"Moir","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"key20210526224342_JCTH-D-21-00051-b49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nri2524","article-title":"B cells in HIV infection and disease","volume":"9","author":"Moir","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"key20210526224342_JCTH-D-21-00051-b50","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2008.05.017","article-title":"Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure","volume":"49","author":"Zhang","year":"2008","journal-title":"J Hepatol"},{"issue":"1","key":"key20210526224342_JCTH-D-21-00051-b51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/gastro\/goaa048","article-title":"Skewed CD39\/CD73\/adenosine pathway contributes to B-cell hyperactivation and disease progression in patients with chronic hepatitis B","volume":"9","author":"Zhou","year":"2020","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"10","key":"key20210526224342_JCTH-D-21-00051-b52","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1038\/nprot.2013.117","article-title":"Isolation of human monoclonal antibodies from peripheral blood B cells","volume":"8","author":"Huang","year":"2013","journal-title":"Nat Protoc"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b53","first-page":"259","article-title":"Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients","volume":"60","author":"Barnaba","year":"1985","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b54","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2567.2008.02833.x","article-title":"Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses","volume":"125","author":"Lee","year":"2008","journal-title":"Immunology"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/eji.1830240215","article-title":"4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells","volume":"24","author":"Pollok","year":"1994","journal-title":"Eur J Immunol"},{"key":"key20210526224342_JCTH-D-21-00051-b56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cellimm.2017.04.012","article-title":"T-bet-expressing B cells during HIV and HCV infections","volume":"321","author":"Knox","year":"2017","journal-title":"Cell Immunol"},{"issue":"4","key":"key20210526224342_JCTH-D-21-00051-b57","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4049\/jimmunol.1500368","article-title":"Cutting edge: B cell-intrinsic T-bet expression is required to control chronic viral infection","volume":"197","author":"Barnett","year":"2016","journal-title":"J Immunol"},{"issue":"34","key":"key20210526224342_JCTH-D-21-00051-b58","doi-asserted-by":"crossref","first-page":"E3216","DOI":"10.1073\/pnas.1312348110","article-title":"T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance","volume":"110","author":"Rubtsova","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"key20210526224342_JCTH-D-21-00051-b59","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ni.2294","article-title":"Divergent transcriptional programming of class-specific B cell memory by T-bet and RORalpha","volume":"13","author":"Wang","year":"2012","journal-title":"Nat Immunol"},{"issue":"1","key":"key20210526224342_JCTH-D-21-00051-b60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"issue":"9","key":"key20210526224342_JCTH-D-21-00051-b61","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1172\/JCI46274","article-title":"Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice","volume":"121","author":"Ding","year":"2011","journal-title":"J Clin Invest"},{"issue":"4","key":"key20210526224342_JCTH-D-21-00051-b62","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/cid\/cis915","article-title":"Hepatitis C therapy: highlights from the 2012 annual meeting of the European Association for the Study of the Liver","volume":"56","author":"Barreiro","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"128","key":"key20210526224342_JCTH-D-21-00051-b63","first-page":"295","article-title":"Characteristics of regulatory B cells in patients with chronic hepatitis B virus infection in different immune phases","volume":"23","author":"Wang","year":"2017","journal-title":"Discov Med"},{"issue":"8","key":"key20210526224342_JCTH-D-21-00051-b64","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/cmi.2017.35","article-title":"B cell regulation in cancer and anti-tumor immunity","volume":"14","author":"Sarvaria","year":"2017","journal-title":"Cell Mol Immunol"},{"issue":"9","key":"key20210526224342_JCTH-D-21-00051-b65","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection","volume":"180","author":"Couper","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"key20210526224342_JCTH-D-21-00051-b66","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis B virus infection","volume":"137","author":"Dunn","year":"2009","journal-title":"Gastroenterology"},{"issue":"12","key":"key20210526224342_JCTH-D-21-00051-b67","doi-asserted-by":"crossref","first-page":"e1001227","DOI":"10.1371\/journal.ppat.1001227","article-title":"Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection","volume":"6","author":"Peppa","year":"2010","journal-title":"PLoS Pathog"},{"issue":"3","key":"key20210526224342_JCTH-D-21-00051-b68","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jhep.2009.12.015","article-title":"A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B","volume":"52","author":"Tan","year":"2010","journal-title":"J Hepatol"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b69","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","article-title":"Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation","volume":"16","author":"Mizoguchi","year":"2002","journal-title":"Immunity"},{"issue":"4","key":"key20210526224342_JCTH-D-21-00051-b70","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.20021293","article-title":"Prevention of arthritis by interleukin 10-producing B cells","volume":"197","author":"Mauri","year":"2003","journal-title":"J Exp Med"},{"issue":"1","key":"key20210526224342_JCTH-D-21-00051-b71","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jhep.2019.07.015","article-title":"Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B","volume":"72","author":"Le Bert","year":"2020","journal-title":"J Hepatol"},{"key":"key20210526224342_JCTH-D-21-00051-b72","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"key20210526224342_JCTH-D-21-00051-b73","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1146\/annurev.immunol.26.021607.090344","article-title":"T follicular helper (TFH) cells in normal and dysregulated immune responses","volume":"26","author":"King","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"key20210526224342_JCTH-D-21-00051-b74","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"key20210526224342_JCTH-D-21-00051-b75","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.imlet.2019.09.003","article-title":"IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression","volume":"216","author":"Gharibi","year":"2019","journal-title":"Immunol Lett"},{"issue":"55","key":"key20210526224342_JCTH-D-21-00051-b76","doi-asserted-by":"crossref","first-page":"55ra78","DOI":"10.1126\/scitranslmed.3000448","article-title":"The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells","volume":"2","author":"Paulos","year":"2010","journal-title":"Sci Transl Med"},{"issue":"33","key":"key20210526224342_JCTH-D-21-00051-b77","doi-asserted-by":"crossref","first-page":"E488","DOI":"10.1073\/pnas.1100898108","article-title":"Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers","volume":"108","author":"Bentebibel","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20210526224342_JCTH-D-21-00051-b78","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.imlet.2016.09.008","article-title":"Altered circulating T follicular helper cell subsets in patients with psoriasis vulgaris","volume":"181","author":"Wang","year":"2017","journal-title":"Immunol Lett"},{"issue":"176","key":"key20210526224342_JCTH-D-21-00051-b79","doi-asserted-by":"crossref","first-page":"176ra132","DOI":"10.1126\/scitranslmed.3005191","article-title":"Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination","volume":"5","author":"Bentebibel","year":"2013","journal-title":"Sci Transl Med"},{"issue":"1","key":"key20210526224342_JCTH-D-21-00051-b80","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"issue":"7","key":"key20210526224342_JCTH-D-21-00051-b81","doi-asserted-by":"crossref","first-page":"e1006484","DOI":"10.1371\/journal.ppat.1006484","article-title":"T follicular helper cells regulate the activation of B lymphocytes and antibody production during Plasmodium vivax infection","volume":"13","author":"Figueiredo","year":"2017","journal-title":"PLoS Pathog"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b82","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.celrep.2015.09.004","article-title":"Circulating Th1-cell-type Tfh cells that exhibit impaired B cell help are preferentially activated during acute malaria in children","volume":"13","author":"Obeng-Adjei","year":"2015","journal-title":"Cell Rep"},{"issue":"5","key":"key20210526224342_JCTH-D-21-00051-b83","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.tim.2016.02.006","article-title":"TFH in HIV latency and as sources of replication-competent virus","volume":"24","author":"Miles","year":"2016","journal-title":"Trends Microbiol"},{"issue":"7348","key":"key20210526224342_JCTH-D-21-00051-b84","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10124","article-title":"A 2020 vision for vaccines against HIV, tuberculosis and malaria","volume":"473","author":"Rappuoli","year":"2011","journal-title":"Nature"},{"issue":"7620","key":"key20210526224342_JCTH-D-21-00051-b85","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature19317","article-title":"Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection","volume":"537","author":"He","year":"2016","journal-title":"Nature"},{"key":"key20210526224342_JCTH-D-21-00051-b86","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1743-422X-11-54","article-title":"Expansion of circulating TFH cells and their associated molecules: involvement in the immune landscape in patients with chronic HBV infection","volume":"11","author":"Hu","year":"2014","journal-title":"Virol J"},{"key":"key20210526224342_JCTH-D-21-00051-b87","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molimm.2016.03.011","article-title":"Tfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-alpha therapy","volume":"73","author":"Zhang","year":"2016","journal-title":"Mol Immunol"},{"issue":"5","key":"key20210526224342_JCTH-D-21-00051-b88","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"issue":"3","key":"key20210526224342_JCTH-D-21-00051-b89","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhep.2019.09.031","article-title":"CXCL13-mediated recruitment of intrahepatic CXCR5(+)CD8(+) T cells favors viral control in chronic HBV infection","volume":"72","author":"Li","year":"2020","journal-title":"J Hepatol"},{"key":"key20210526224342_JCTH-D-21-00051-b90","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.3389\/fimmu.2018.02287","article-title":"A subset of CXCR5(+)CD8(+) T cells in the germinal centers from human tonsils and lymph nodes help B cells produce immunoglobulins","volume":"9","author":"Shen","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b91","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yexcr.2018.02.031","article-title":"Circulating regulatory Tfh cells are enriched in patients with chronic hepatitis B infection and induce the differentiation of regulatory B cells","volume":"365","author":"Wang","year":"2018","journal-title":"Exp Cell Res"},{"issue":"8","key":"key20210526224342_JCTH-D-21-00051-b92","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1053\/j.gastro.2018.03.021","article-title":"Dysregulated response of follicular helper T cells to hepatitis B surface antigen promotes HBV persistence in mice and associates with outcomes of patients","volume":"154","author":"Wang","year":"2018","journal-title":"Gastroenterology"},{"issue":"42","key":"key20210526224342_JCTH-D-21-00051-b93","doi-asserted-by":"crossref","first-page":"16993","DOI":"10.1073\/pnas.1306437110","article-title":"Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice","volume":"110","author":"Xu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"key20210526224342_JCTH-D-21-00051-b94","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41423-018-0006-2","article-title":"Type III interferon-induced CBFbeta inhibits HBV replication by hijacking HBx","volume":"16","author":"Xu","year":"2019","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"key20210526224342_JCTH-D-21-00051-b95","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/jmv.24013","article-title":"Extended peginterferon alfa-2a (Pegasys) therapy in Chinese patients with HBeAg-negative chronic hepatitis B","volume":"86","author":"Chen","year":"2014","journal-title":"J Med Virol"},{"issue":"3","key":"key20210526224342_JCTH-D-21-00051-b96","first-page":"249","article-title":"A potential functional cure in Chinese HBeAg-negative chronic hepatitis B patients treated with peg-interferon alpha-2a","volume":"7","author":"Chen","year":"2019","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"key20210526224342_JCTH-D-21-00051-b97","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"European Association For The Study Of The Liver.EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"issue":"8","key":"key20210526224342_JCTH-D-21-00051-b98","first-page":"627","article-title":"Pegasys and ribavirin therapy in an elderly patient with chronic hepatitis C","volume":"19","author":"Xue","year":"2011","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b99","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jhep.2012.09.029","article-title":"Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B","volume":"58","author":"Micco","year":"2013","journal-title":"J Hepatol"},{"key":"key20210526224342_JCTH-D-21-00051-b100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/1743-422X-9-274","article-title":"Pegylated interferon alpha enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients","volume":"9","author":"Liu","year":"2012","journal-title":"Virol J"},{"issue":"7","key":"key20210526224342_JCTH-D-21-00051-b101","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/infdis\/jiv180","article-title":"Natural killer cell characteristics in patients with chronic hepatitis B virus (HBV) infection are associated with HBV surface antigen clearance after combination treatment with pegylated interferon alfa-2a and adefovir","volume":"212","author":"Stelma","year":"2015","journal-title":"J Infect Dis"},{"issue":"7","key":"key20210526224342_JCTH-D-21-00051-b102","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1172\/JCI118592","article-title":"Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection","volume":"97","author":"Rehermann","year":"1996","journal-title":"J Clin Invest"},{"issue":"6","key":"key20210526224342_JCTH-D-21-00051-b103","doi-asserted-by":"crossref","first-page":"e0156200","DOI":"10.1371\/journal.pone.0156200","article-title":"Remodeling of B-cell subsets in blood during pegylated IFNalpha-2a therapy in patients with chronic hepatitis B infection","volume":"11","author":"Aspord","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b104","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2567.2006.02354.x","article-title":"Deciphering CD30 ligand biology and its role in humoral immunity","volume":"118","author":"Kennedy","year":"2006","journal-title":"Immunology"},{"issue":"18","key":"key20210526224342_JCTH-D-21-00051-b105","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1021\/jm400815m","article-title":"Identification and optimization of pteridinone Toll-like receptor 7 (TLR7) agonists for the oral treatment of viral hepatitis","volume":"56","author":"Roethle","year":"2013","journal-title":"J Med Chem"},{"issue":"5","key":"key20210526224342_JCTH-D-21-00051-b106","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2017.12.008","article-title":"Anti-HBV response to toll-like receptor 7 agonist GS-9620 is associated with intrahepatic aggregates of T cells and B cells","volume":"68","author":"Li","year":"2018","journal-title":"J Hepatol"},{"issue":"6","key":"key20210526224342_JCTH-D-21-00051-b107","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10875-004-6244-3","article-title":"CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I\/II study","volume":"24","author":"Cooper","year":"2004","journal-title":"J Clin Immunol"},{"issue":"5","key":"key20210526224342_JCTH-D-21-00051-b108","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","article-title":"Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B","volume":"15","author":"Wang","year":"2020","journal-title":"Nat Nanotechnol"},{"issue":"2","key":"key20210526224342_JCTH-D-21-00051-b109","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/gutjnl-2018-317725","article-title":"A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice","volume":"69","author":"Zhang","year":"2020","journal-title":"Gut"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:19:55Z","timestamp":1783707595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":109,"journal-issue":{"issue":"000","published-online":{"date-parts":[[2021,5,27]]},"published-print":{"date-parts":[[2021,5,27]]}},"alternative-id":["10.14218\/JCTH.2021.00051"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2021.00051","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]}}}